BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26286753)

  • 1. Getting controls under control: the time is now for immunohistochemistry.
    Torlakovic EE; Nielsen S; Vyberg M; Taylor CR
    J Clin Pathol; 2015 Nov; 68(11):879-82. PubMed ID: 26286753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
    Torlakovic EE; Nielsen S; Francis G; Garratt J; Gilks B; Goldsmith JD; Hornick JL; Hyjek E; Ibrahim M; Miller K; Petcu E; Swanson PE; Zhou X; Taylor CR; Vyberg M
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):1-18. PubMed ID: 25474126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fit-for-Purpose Immunohistochemical Biomarkers.
    Torlakovic EE
    Endocr Pathol; 2018 Jun; 29(2):199-205. PubMed ID: 29696583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding pitfalls in diagnostic immunohistochemistry-important technical aspects that every pathologist should know.
    Miller RT
    Semin Diagn Pathol; 2019 Sep; 36(5):312-335. PubMed ID: 31227425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry practices of cytopathology laboratories: a survey of participants in the College of American Pathologists Nongynecologic Cytopathology Education Program.
    Fischer AH; Schwartz MR; Moriarty AT; Wilbur DC; Souers R; Fatheree L; Booth CN; Clayton AC; Kurtyz DF; Padmanabhan V; Crothers BA
    Arch Pathol Lab Med; 2014 Sep; 138(9):1167-72. PubMed ID: 24840035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ICC and IHC: techniques and quality assurance. Lessons from the French external quality assessment trials in IHC].
    Bellocq JP; Michiels JF; Egele C; Chenard MP
    Ann Pathol; 2012 Nov; 32(5 Suppl):S94-5. PubMed ID: 23127954
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
    Torlakovic EE; Francis G; Garratt J; Gilks B; Hyjek E; Ibrahim M; Miller R; Nielsen S; Petcu EB; Swanson PE; Taylor CR; Vyberg M;
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):241-52. PubMed ID: 24714041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The total test approach to standardization of immunohistochemistry.
    Drachenberg CB; Papadimitriou JC; Balaton AJ; Vaury P
    Arch Pathol Lab Med; 2001 Apr; 125(4):471. PubMed ID: 11260616
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of diagnostic immunohistochemistry on patient outcomes.
    Wick MR; Ritter JH; Swanson PE
    Clin Lab Med; 1999 Dec; 19(4):797-814, vi. PubMed ID: 10572716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.
    Thunnissen E; Allen TC; Adam J; Aisner DL; Beasley MB; Borczuk AC; Cagle PT; Capelozzi VL; Cooper W; Hariri LP; Kern I; Lantuejoul S; Miller R; Mino-Kenudson M; Radonic T; Raparia K; Rekhtman N; Roy-Chowdhuri S; Russell P; Schneider F; Sholl LM; Tsao MS; Vivero M; Yatabe Y
    Arch Pathol Lab Med; 2018 Mar; 142(3):408-419. PubMed ID: 28686497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry in surgical pathology: principles and practice.
    Taylor CR
    Methods Mol Biol; 2014; 1180():81-109. PubMed ID: 25015143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Audit of Failed Immunohistochemical Slides in a Clinical Laboratory: The Role of On-Slide Controls.
    Cheung CC; Taylor CR; Torlakovic EE
    Appl Immunohistochem Mol Morphol; 2017; 25(5):308-312. PubMed ID: 26657875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of Analytic Validation of Clinical Immunohistochemistry Assays.
    Goldsmith JD; Fitzgibbons PL; Swanson PE
    Adv Anat Pathol; 2015 Nov; 22(6):384-7. PubMed ID: 26452213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External quality assessment for immunohistochemistry: experiences from NordiQC.
    Nielsen S
    Biotech Histochem; 2015 Jul; 90(5):331-40. PubMed ID: 25901597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of immunohistochemistry for biomarker assessment--can it compete with other technologies?
    Dunstan RW; Wharton KA; Quigley C; Lowe A
    Toxicol Pathol; 2011 Oct; 39(6):988-1002. PubMed ID: 21971934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry utilization in autopsy pathology: a Canadian experience.
    Bromley AB; Trotter MJ
    Pathol Res Pract; 2011 Apr; 207(4):241-6. PubMed ID: 21440379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of diagnostic immunohistochemistry: literature review and geisinger experience.
    Lin F; Chen Z
    Arch Pathol Lab Med; 2014 Dec; 138(12):1564-77. PubMed ID: 25427038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory.
    Berg J; Lane V
    Ann Clin Biochem; 2011 May; 48(Pt 3):195-7. PubMed ID: 21555538
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of performing immunohistochemistry on cases with a previous diagnosis of cancer coming to a national comprehensive cancer center for treatment or second opinion.
    Wetherington RW; Cooper HS; Al-Saleem T; Ackerman DS; Adams-McDonnell R; Davis W; Ehya H; Patchefsky AS; Suder J; Young NA
    Am J Surg Pathol; 2002 Sep; 26(9):1222-30. PubMed ID: 12218579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse spleen tissue as a staining intensity reference for immunohistochemistry.
    Moon Y; Park G; Han K; Kang CS; Lee W
    Ann Clin Lab Sci; 2008; 38(3):215-20. PubMed ID: 18715848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.